Regeneron Pharmaceuticals Inc REGN:NASDAQ

Last Price$399.14NASDAQ Previous Close - Last Trade as of 4:00PM ET 2/20/20

Today's Change-1.67(0.42%)
Bid (Size)$391.00 (1)
Ask (Size)$399.14 (1)
Day Low / High$393.76 - 401.09
Volume660.8 K

Analysts' Scale Up Regeneron Pharmaceuticals' Q3, 2019, 2020 Earnings Estimates

5:41PM ET 8/08/2019 MT Newswires
Regeneron Pharmaceuticals Inc's (NASDAQ:REGN, Recent Price: 302.22) forecasted earnings estimates for Q3 ending September 30, 2019, and the expectations for 2019 and 2020 have been scaled up. The Q3 earnings estimate has been raised to $6.16 per share, up from the previous consensus forecast of $5.41 per share, as have the full year estimates for 2019 and 2020. The 2019 estimate has been raised to $22.95 per share from the previous consensus estimate of $21.75 per share and the full year 2020 estimate has been increased from $24.21 per share to $24.95 per share. Currently, there are 17 estimates used to compile the Q3 forecast and 21 and 22 distributed estimates incorporated in the full year forecasts for 2019 and 2020, respectively.